Aframomum citratum
What's the taxonomical classification of Aframomum citratum?
Aframomum citratum belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is categorized under the class Equisetopsida and the subclass Magnoliidae. The plant is further organized into the order Zingiberales and the family Zingiberaceae, which is a group well known for its aromatic qualities. Finally, its specific taxonomic identity is defined by its placement within the genus Aframomum, with its unique biological classification completed at the species level as citratum.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Zingiberales |
| Family | Zingiberaceae |
| Genus | Aframomum |
| Species | citratum |
What are the morphological characteristics of this plant?
Aframomum citratum has an upright, herbaceous growth habit characterized by long, lanceolate leaves that emerge from thick, rhizomatous stems. The foliage is bright green with prominent parallel venation and smooth margins. Small, inconspicuous white or cream-colored flowers emerge from the leaf axils in dense, spike-like inflorescences. These flowers eventually give rise to small, fleshy berries that are typically dark in color when mature. The plant's structure is defined by its dense, clump-forming nature and its ability to spread through underground rhizome expansion.
What is the geographical distribution of this plant?
This plant is native to the tropical and subtropical regions of sub-Saharan Africa, spanning from West Africa through Central Africa to parts of East Africa. It thrives primarily in moist, shaded environments such as lowland rainforests and riverine thickets. The species is frequently found in high-humidity habitats where forest undergrowth is dense. Its distribution follows the patterns of tropical vegetation zones across the African continent. This specific range allows the plant to access the consistent moisture necessary for its growth.
How is this plant cultivated?
This plant, commonly known as citronella grass, requires well-draining soil and a tropical climate with consistent moisture and temperatures above 60 degrees Fahrenheit to thrive.
Cultivation begins by planting rhizome cuttings or slips in nutrient-rich, organic soil during the warm growing season. It thrives in full sun to partial shade, provided that the soil remains damp but never waterlogged to prevent root rot. Regular weeding and the application of compost help maintain vigorous growth for essential oil production.
Once the plant reaches maturity, the leaves are harvested to extract the fragrant oils used in various industries.
What parts of this plant are used medicinally?
Aframomum citratum contains medicinal compounds primarily located within its aromatic seeds and rhizomes. The seeds are highly valued for their essential oils, which are often harvested to treat digestive ailments and respiratory issues. Additionally, the rhizomes are processed to extract bioactive substances used in traditional remedies for inflammation and stomach pain. Many cultures also utilize the leaves in decoctions to manage fever or other minor infections. These various plant parts work together to provide a wide range of therapeutic properties.
What traditional systems uses this plant?
This plant, known as citronella cardamom, has been historically utilized by various ethnic groups in West and Central Africa as a potent medicinal remedy for digestive ailments, respiratory infections, and skin inflammations.
Traditional healers often prepare decoctions from the dried seeds to alleviate stomach pains or treat feverish symptoms. In many local cultures, the aromatic seeds are also integrated into culinary practices to enhance the flavor of ceremonial dishes. Beyond its dietary uses, the plant serves a role in ritualistic ceremonies where its distinct scent is believed to possess purifying properties.
These long-standing practices highlight the deep integration of the species into the sociocultural fabric of the regions where it grows natively.
What are the pharmacological activities of Aframomum citratum?
This plant has anti-inflammatory, antibacterial, antioxidant, α-amylase inhibitory, and α-glucosidase inhibitory activities. Its phytochemical constituents contribute to reducing oxidative stress and fighting harmful bacterial pathogens. The presence of specific bioactive compounds also helps modulate inflammatory responses within biological systems. Furthermore, the plant demonstrates potential in managing glucose metabolism by inhibiting key enzymes involved in carbohydrate digestion. These combined pharmacological properties suggest significant therapeutic potential for various metabolic and infectious conditions.
According to a study published by "Nutrients", Aframomum citratum is one of the six extracts selected for further studies following a preliminary screening on TNFα-induced NF-κB driven transcription. The hydro-alcoholic extracts of this plant demonstrated antioxidant properties in a cell-free system and reduced H2O2-induced ROS generation in gastric epithelial cells. This plant exhibited anti-inflammatory activity by reducing the expression of NF-κB-dependent pro-inflammatory mediators such as IL-8 and IL-6. Furthermore, the extract reduced the expression of enzymes like PTGS2 (COX-2) without affecting PTGS1 (COX-1). These findings show that the extract decreases pro-inflammatory markers by inhibiting the NF-κB signaling in gastric cells.
The primary pharmacological activities of this plant are shown in the list below.
- anti-inflammatory
- antibacterial
- antioxidant
- α-amylase inhibitory activity
- α-glucosidase inhibitory activity
What medicinal compounds this plant contains?
This plant contains a diverse array of medicinal phenols including 4-O-methyl gallic acid, 4-caffoeylquinic acid, 5-caffoeylshikimic acid, and chlorogenic acid. These specific chemical constituents contribute to the overall therapeutic profile of the species. The presence of these organic compounds is often linked to the plant's antioxidant and anti-inflammatory properties. Researchers study these particular molecules to understand how they interact with biological systems. Such chemical complexity makes the plant a subject of interest in pharmacological investigations.
According to a study published by "Food & function", hydroethanolic extracts of Aframomum citratum were chemically characterized using GC-MS analysis. These extracts showed a strong and selected activity on pancreatic lipase. Chemical analysis indicated that secondary metabolites found in Aframomum citratum include chlorogenic acid, pimaric acid, and catechin and its derivatives. These specific compounds could potentially justify the biological properties observed in the plant. The study suggests that such extracts may be useful for developing management strategies for obesity and diabetes complications.
The primary medicinal compounds of this plant are shown in the list below.
- 4-O-methyl gallic acid
- 4-caffeoylquinic acid
- 5-caffeoylshikimic acid
- chlorogenic acid
- phenols
What health conditions is this plant used for?
This plant is used for treating gastritis, the gastric inflammatory process, general inflammation, diabetes, and obesity. It contains bioactive compounds that help reduce swelling and irritation within the digestive tract. These properties assist in soothing the stomach lining to combat various inflammatory conditions. Additionally, the plant is utilized to help manage blood sugar levels and support weight regulation. By addressing these metabolic issues, it serves as a versatile tool in managing chronic health concerns.
According to a study published by "Antioxidants (Basel, Switzerland)", Aframomum citratum is used to potentially suppress acute or chronic inflammation and reduce the harmful effects of gastritis. The extract contains a high amount of total phenolic content ranging from 150-290 mg gallic acid equivalents (GAE)/g and a total flavonoid content of 35-115 mg catechin equivalents (CE)/g. It exhibits antioxidant properties with a 1,1-Diphenyl-2-picryl-hydrazyl (DPPH) half maximal inhibitory concentration (IC50) ≤ 45 µg/mL and a 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) half maximal inhibitory concentration (IC50) ≤ 29 µg/mL. When used in combination, it exerts a synergistic beneficial effect on inflammatory markers like interleukin (IL)-8, IL-6, and nuclear factor kappa B (NF-κB) driven transcription in human gastric epithelial cells. This synergy is characterized by combination index (CIs) < 1 and dose reduction index (DRIs) > 1.
The main health conditions this plant is used for are shown in the list below.
- carbohydrate digestion
- gastric inflammatory process
- gastritis
- lipid digestion
- inflammation
What are the herbal preparations of this plant?
This plant is used to create medicinal herbal preparations such as extracts, tinctures, and powders to treat digestive issues and inflammation. These preparations often concentrate the essential oils and bioactive compounds found within the seeds. Extracts are particularly valued because they provide a potent, standardized dose of the plant's therapeutic properties. Practitioners frequently use these liquid forms to enhance the bioavailability of the active constituents in the body. This versatility makes the plant a significant component in various traditional and modern herbal remedies.
According to a study published by "Antioxidants (Basel, Switzerland)", Aframomum citratum is a Cameroonian spice extract characterized through RP-HPLC, UPLC-ESI-HRMS/MS, and FTIR analyses. The extract shows a total phenolic content (TPC) of 150-290 mg gallic acid equivalents (GAE)/g and a total flavonoid content (TFC) of 35-115 mg catechin equivalents (CE)/g. It exhibits antioxidant properties in a cell-free system with a DPPH half maximal inhibitory concentration (IC50) ≤ 45 µg/mL and an ABTS half maximal inhibitory concentration (IC50) ≤ 29 µg/mL. When used in combination (MIX), the extract exerts a synergistic beneficial effect on inflammatory markers like IL-8 and IL-6 release, indicated by combination indices (CIs) < 1 and dose reduction indices (DRIs) > 1. These effects in human gastric epithelial cells may result from phenolic acids, flavonoids, proteins, lipids, aromatic compounds, or polysaccharides.
The main herbal preparations of this plant are shown in the list below.
- extracts
What side effects this plant can have?
This plant can cause unknown health complications due to the insufficient clinical data currently available to identify specific side effects. Because rigorous human studies are lacking, the potential for adverse reactions remains largely undocumented in medical literature. Researchers have not yet established a clear profile regarding toxicity levels or long-term impacts on human organs. This lack of scientific evidence means that users cannot accurately predict how the plant might interact with medications or underlying health conditions. Consequently, caution is advised when consuming this species until more comprehensive clinical trials are conducted.
The main side effects this plant can have are shown in the list below.
- Insufficient clinical data to identify specific side effects
What herbs are paired with Aframomum citratum?
This plant, commonly known as citronella cardamom, pairs most effectively with citrus herbs like lemongrass and lemon balm to enhance its bright, lemony aromatic profile.
It also complements earthy spices such as ginger and turmeric, which ground its high-toned citrus notes with warm undertones. When used in savory applications, it integrates seamlessly with woody herbs like rosemary or thyme to provide a refreshing contrast to heavy fats. For sweet preparations, pairing it with mint or basil creates a complex herbal melody that highlights its unique botanical structure.
These combinations allow the distinctive citronella scent to blend harmoniously within various culinary and medicinal blends.